DK0975327T3 - Anvendelse af 5HT3-antagonister til befordring af tarmudskylning - Google Patents

Anvendelse af 5HT3-antagonister til befordring af tarmudskylning

Info

Publication number
DK0975327T3
DK0975327T3 DK98922759T DK98922759T DK0975327T3 DK 0975327 T3 DK0975327 T3 DK 0975327T3 DK 98922759 T DK98922759 T DK 98922759T DK 98922759 T DK98922759 T DK 98922759T DK 0975327 T3 DK0975327 T3 DK 0975327T3
Authority
DK
Denmark
Prior art keywords
antagonists
intestinal lavage
promote intestinal
lavage
promote
Prior art date
Application number
DK98922759T
Other languages
English (en)
Inventor
Antonius Adrianus Hendr Megens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK0975327T3 publication Critical patent/DK0975327T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK98922759T 1997-04-18 1998-04-14 Anvendelse af 5HT3-antagonister til befordring af tarmudskylning DK0975327T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97201149 1997-04-18
PCT/EP1998/002356 WO1998047481A1 (en) 1997-04-18 1998-04-14 Use of 5ht3 antagonists for promoting intestinal lavage

Publications (1)

Publication Number Publication Date
DK0975327T3 true DK0975327T3 (da) 2003-10-20

Family

ID=8228223

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98922759T DK0975327T3 (da) 1997-04-18 1998-04-14 Anvendelse af 5HT3-antagonister til befordring af tarmudskylning

Country Status (12)

Country Link
US (2) US6235745B1 (da)
EP (1) EP0975327B1 (da)
JP (1) JP2001523239A (da)
KR (1) KR100529512B1 (da)
AT (1) ATE243993T1 (da)
AU (1) AU745361B2 (da)
CA (1) CA2286076C (da)
DE (1) DE69816060T2 (da)
DK (1) DK0975327T3 (da)
ES (1) ES2202855T3 (da)
PT (1) PT975327E (da)
WO (1) WO1998047481A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1090638A1 (en) * 1999-10-08 2001-04-11 Sanofi-Synthelabo Use of (R)-zacopride or a salt thereof for the manufacture of a medicament for the treatment of sleep apnea
WO2002041918A2 (en) * 2000-11-24 2002-05-30 Janssen Pharmaceutica N.V. Use of a triple combination comprising a 5ht3 antagonist, a 5ht4 agonist and a laxative for promoting intestinal lavage
PE20021019A1 (es) * 2001-04-19 2002-11-13 Upjohn Co Grupos azabiciclicos sustituidos
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
TWI332943B (en) * 2001-07-10 2010-11-11 Synta Pharmaceuticals Corp Taxol enhancer compounds
US6946149B2 (en) * 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
JP2006503864A (ja) * 2002-10-01 2006-02-02 ジヨンソン・アンド・ジヨンソン・フアーマシユーチカル・リサーチ・アンド・デベロツプメント・インコーポレーテツド タンパク質チロシンキナーゼ阻害剤としての４，６−ジアミノ置換−２−［オキシ又はアミノキシ］−［１，３，５］トリアジン
US6996500B2 (en) * 2002-10-30 2006-02-07 Hewlett-Packard Development Company, L.P. Method for communicating diagnostic data
US20040147510A1 (en) * 2003-01-13 2004-07-29 Dynogen Pharmaceuticals, Inc. Method of treating nausea, vomiting, retching or any combination thereof
AU2004204825B2 (en) * 2003-01-13 2007-07-19 Dynogen Pharmaceuticals, Inc. Method of treating functional bowel disorders
DE602004007225T2 (de) 2003-04-04 2008-03-06 Dynogen Pharmaceuticals Inc., Waltham Methode zur behandlung von erkrankungen der unteren harnwege
US7049319B2 (en) * 2003-09-23 2006-05-23 Semaan Abboud Colon cleansing composition and method
JPWO2005099698A1 (ja) * 2004-04-15 2008-03-06 エーザイ・アール・アンド・ディー・マネジメント株式会社 安定化された４−アミノ−５−クロロ−Ｎ−［（１Ｒ，３ｒ，５Ｓ）−８−メチル−８−アザビシクロ［３．２．１］オクタ−３−イル］−２−［１−メチルブタ−２−インイルオキシ］ベンズアミド含有組成物
US20060293309A1 (en) * 2005-03-28 2006-12-28 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
WO2007019888A2 (en) * 2005-08-12 2007-02-22 Ctg Pharma S.R.L. Therapeutic compositions containing mesalamine and a co-agent for treating colon diseases
JP2009504740A (ja) * 2005-08-16 2009-02-05 シンタ ファーマシューティカルズ コーポレーション ビス（チオ−ヒドラジドアミド）製剤
JP2009506069A (ja) * 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
MX2009001494A (es) 2006-08-07 2009-04-23 Albany Molecular Res Inc 2-aminobenzoxazol carboxamidas como moduladores 5ht3.
US7553846B2 (en) 2006-08-07 2009-06-30 Albany Molecular Research, Inc. 2-alkylbenzoxazole carboxamides as 5-HT3 modulators
AU2014218599C1 (en) * 2013-02-25 2018-09-06 Bausch Health Ireland Limited Guanylate cyclase receptor agonists for use in colonic cleansing
WO2014144407A1 (en) 2013-03-15 2014-09-18 Braintree Laboratories, Inc. Dual use oral pharmaceutical composition tablets of sulfate saltes and methods of use thereof
US10172833B2 (en) 2015-08-11 2019-01-08 Insys Development Company, Inc. Sublingual ondansetron spray
US10143656B1 (en) 2017-08-04 2018-12-04 Braintree Laboratories, Inc. Solid oral sulfate salt formulations for cleaning a colon and methods of using same
EP3858828A4 (en) * 2018-09-28 2022-07-06 Takeda Pharmaceutical Company Limited HETEROCYCLIC COMPOUND

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB893267A (en) 1958-11-25 1962-04-04 Sterling Drug Inc Laxative enemas
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
TW294595B (da) 1992-11-20 1997-01-01 Janssen Pharmaceutica Nv
US6103734A (en) 1994-11-04 2000-08-15 Legarda Ibanez; Juan Jose Drug combination as a medicament to suppress the dependence of individuals to opiates
WO1996014071A1 (es) 1994-11-04 1996-05-17 Legarda Ibanez Juan Jose Combinacion de farmacos como medicamento destinado a supresion de dependencia de individuos a opiaceos
US5576317A (en) * 1994-12-09 1996-11-19 Pfizer Inc. NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis

Also Published As

Publication number Publication date
ATE243993T1 (de) 2003-07-15
KR20000075858A (ko) 2000-12-26
KR100529512B1 (ko) 2005-11-22
AU7528298A (en) 1998-11-13
AU745361B2 (en) 2002-03-21
CA2286076A1 (en) 1998-10-29
DE69816060D1 (de) 2003-08-07
US20010020025A1 (en) 2001-09-06
EP0975327B1 (en) 2003-07-02
DE69816060T2 (de) 2004-04-22
US6555546B2 (en) 2003-04-29
JP2001523239A (ja) 2001-11-20
EP0975327A1 (en) 2000-02-02
ES2202855T3 (es) 2004-04-01
US6235745B1 (en) 2001-05-22
CA2286076C (en) 2006-12-12
PT975327E (pt) 2003-11-28
WO1998047481A1 (en) 1998-10-29

Similar Documents

Publication Publication Date Title
DK0975327T3 (da) Anvendelse af 5HT3-antagonister til befordring af tarmudskylning
TR200000782T2 (tr) Resorsinol türevleri.
ES2195970T3 (es) L-ribavirina y usos de la misma.
ATE253073T1 (de) Neue benzimidazol inhibitoren der fructose-1,6- bisphosphatase
MXPA03001511A (es) Imidazol-5-il-2-amino-pirimidinas como agentes para la inhibicion de la proliferacion celular.
BR0215405A (pt) Composições e processos de uso de collajolie
EA199900373A2 (ru) Фармацевтические композиции
DK1413582T3 (da) Dimere pyrrolobenzodiazepiner
DE60106954D1 (de) Resorcin-derivate
UY34152A (es) ?oxazolidinonas substituidas y su uso?.
SE9702773D0 (sv) Novel compounds
EA200300593A1 (ru) Соединения пиперазинилпиразинов в качестве агонистов или антагонистов серотонин 5-ht2 рецептора
BR0007864A (pt) Composto, e, uso de um composto
AR016981A2 (es) Polipeptidos sinteticos
EA200001039A1 (ru) Кальцилитические соединения
EA200000536A1 (ru) Применение комбинации ингибитора конвертирующего фермента и диуретика для лечения нарушений микроциркуляции
DE69804198D1 (de) Zementschlamm für die zementierung von bohrlöchern insbesondere ölbohrlöchern
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
TR200102742T2 (tr) Rezorsinol türevleri
ES2180319T3 (es) Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos.
TR200103448T2 (tr) IL-8 reseptör antagonistleri.
DK1220667T3 (da) Beta-antagonister til behandling af endometriose eller ufrugtbarhed, eller til forbedring af frugtbarheden
EA200200798A1 (ru) Кальцилитические соединения
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer